Robinson Chandler insider trades
Robinson Chandler has filed 32 Form 4s with the SEC that we hold, all for Monopar Therapeutics (MNPR), as Chief Executive Officer, Director. Across all of them we count 0 purchases worth $0 and 5 sales worth $3.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 4 sales ($2.6M). The largest single trade was a sale of 10,450 shares of Monopar Therapeutics worth $910.7K, dated 2026-09-24. Of 4 sales filed since we began reading the 10b5-1 checkbox, 4 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-07-02 and the latest 2026-10-20.
Monopar Therapeutics (MNPR)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2025-07-14 | S, sale reported on Form 4 | 16,800 | $672.0K | 2025-07-16 | SEC |
| 2026-09-24 | S, sale reported on Form 4 | 10,450 | $910.7K | 2026-09-28 | SEC |
| 2026-09-24 | S, sale reported on Form 4 | 9,638 | $847.8K | 2026-09-28 | SEC |
| 2026-09-24 | S, sale reported on Form 4 | 8,368 | $744.5K | 2026-09-28 | SEC |
| 2026-09-24 | S, sale reported on Form 4 | 600 | $53.9K | 2026-09-28 | SEC |
Counted from the Form 4 filings this reporting owner (SEC CIK 1727334) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
